Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MADRIGAL PHARMACEUTICALS, INC.

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL)
Listen to this Section


$489.69
-3.1400 ( -0.64% ) 75.7K

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Market Data


Open $489.69
Previous Close $492.83
Volume 75.7K
Market Cap $11.25B
Day Range $472.80 - $495.19
52 Week Range $271.96 - $615.00
Shares Outstanding 23.06M
Change % -0.64%
Net Change ▼ -3.1400
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2007
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 2,814.00

Date Type Amount Purchased Purchaser
2025-08-20 Buy 177.00 BAKER BROS. ADVISORS LP
2025-08-20 Buy 2460.00 BAKER BROS. ADVISORS LP
2025-08-20 Buy 177.00 BAKER BROS. ADVISORS LP

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 07, 2025
10-q Quarterly Reports 109 Nov 04, 2025
8-k 8K-related 16 Nov 04, 2025
4 Insider transactions 1 Sep 09, 2025
4 Insider transactions 1 Aug 21, 2025
4 Insider transactions 1 Aug 20, 2025
4 Insider transactions 1 Aug 20, 2025
4 Insider transactions 1 Aug 18, 2025
4 Insider transactions 1 Aug 15, 2025
4 Insider transactions 1 Aug 13, 2025

Latest News


× Before browsing our site, please accept our cookies policy